Senior Editor – Europe
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From David Ridley
Daily contraceptives and high-dose statins are two OTC categories that have future switch potential, according to UK self-care industry association CEO John Smith.